These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28011801)

  • 1. Impact of haemodynamic SonR sensor on monitoring of left ventricular function in patients undergoing cardiac resynchronization therapy.
    Sacchi S; Pieragnoli P; Ricciardi G; Grifoni G; Padeletti L
    Europace; 2017 Oct; 19(10):1695-1699. PubMed ID: 28011801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Myocardial Contractility by SonR Sensor in Patients Undergoing Cardiac Resynchronization Therapy.
    Sacchi S; Perini AP; Attanà P; Grifoni G; Chiostri M; Ricciardi G; Pieragnoli P; Padeletti L
    Pacing Clin Electrophysiol; 2016 Mar; 39(3):268-74. PubMed ID: 26644068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Hemodynamic Device-Based Optimization in Heterogeneous Patients Implanted with Cardiac Resynchronization Therapy Defibrillator.
    Covino G; Volpicelli M; Ciardiello C; Capogrosso P
    J Cardiovasc Transl Res; 2020 Dec; 13(6):938-943. PubMed ID: 32385806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.
    Galve E; Oristrell G; Acosta G; Ribera-Solé A; Moya-Mitjans À; Ferreira-González I; Pérez-Rodon J; García-Dorado D
    Clin Cardiol; 2018 Jun; 41(6):803-808. PubMed ID: 29604094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study.
    Gierula J; Lowry JE; Paton MF; Cole CA; Byrom R; Koshy AO; Chumun H; Kearney LC; Straw S; Bowen TS; Cubbon RM; Keenan AM; Stocken DD; Kearney MT; Witte KK
    Circulation; 2020 May; 141(21):1693-1703. PubMed ID: 32299222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
    Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
    Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and long-term outcome of super-responders to cardiac resynchronization therapy.
    Ghani A; Delnoy PPHM; Adiyaman A; Ottervanger JP; Ramdat Misier AR; Smit JJJ; Elvan A
    Clin Cardiol; 2017 May; 40(5):292-299. PubMed ID: 28294364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contractibility sensor signal evolution predicts cardiovascular events in patients with cardiac resynchronization therapy.
    Garcia R; Guenancia C; Le Gal F; Rehman M; Tao V; Christiaens L; Ingrand P; Degand B
    Arch Cardiovasc Dis; 2019 Jan; 112(1):22-30. PubMed ID: 30591324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of multisite left ventricular pacing via quadripolar lead improves acute haemodynamics and mechanical dyssynchrony assessed by radial strain speckle tracking: initial results.
    Osca J; Alonso P; Cano O; Andrés A; Miro V; Tello MJ; Olagüe J; Martínez L; Salvador A
    Europace; 2016 Apr; 18(4):560-7. PubMed ID: 26333378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Stephansen C; Sommer A; Kronborg MB; Jensen JM; Nørgaard BL; Gerdes C; Kristensen J; Jensen HK; Fyenbo DB; Bouchelouche K; Nielsen JC
    Europace; 2019 Sep; 21(9):1369-1377. PubMed ID: 31274152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter-Defibrillator.
    Kim M; Kim J; Lee JH; Hwang YM; Kim MS; Nam GB; Choi KJ; Kim JJ; Kim YH
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1191-1198. PubMed ID: 27334231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive, model-based measures of ventricular electrical dyssynchrony for predicting CRT outcomes.
    Villongco CT; Krummen DE; Omens JH; McCulloch AD
    Europace; 2016 Dec; 18(suppl 4):iv104-iv112. PubMed ID: 28011837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OptiVol fluid index: does an association with ventricular arrhythmias hold water?
    Sullivan RM; Olshansky B
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):300-1. PubMed ID: 21091968
    [No Abstract]   [Full Text] [Related]  

  • 16. Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy.
    Killu AM; Mazo A; Grupper A; Madhavan M; Webster T; Brooke KL; Hodge DO; Asirvatham SJ; Friedman PA; Glikson M; Cha YM
    Europace; 2018 Aug; 20(8):1303-1311. PubMed ID: 29016821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional Longitudinal Deformation Improves Prediction of Ventricular Tachyarrhythmias in Patients With Heart Failure With Reduced Ejection Fraction: A MADIT-CRT Substudy (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
    Biering-Sørensen T; Knappe D; Pouleur AC; Claggett B; Wang PJ; Moss AJ; Solomon SD; Kutyifa V
    Circ Cardiovasc Imaging; 2017 Jan; 10(1):. PubMed ID: 28003221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Anatomically Designed Quadripolar Left Ventricular Leads: Results from the NAVIGATE X4 Clinical Trial.
    Mittal S; Nair D; Padanilam BJ; Ciuffo A; Gupta N; Gallagher P; Goldner B; Hammill EF; Wold N; Stein K; Burke M
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1199-1205. PubMed ID: 27434039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of electro-mechanical remodeling to survival rates after cardiac resynchronization therapy.
    Kiani J; Agarwal SK; Kamireddy S; Adelstein E; Saba S
    Tex Heart Inst J; 2013; 40(3):268-73. PubMed ID: 23914016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization is pro-arrhythmic in the absence of reverse ventricular remodelling: a systematic review and meta-analysis.
    Deif B; Ballantyne B; Almehmadi F; Mikhail M; McIntyre WF; Manlucu J; Yee R; Sapp JL; Roberts JD; Healey JS; Leong-Sit P; Tang AS
    Cardiovasc Res; 2018 Sep; 114(11):1435-1444. PubMed ID: 30010807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.